Search for: "New Jersey v. Delaware"
Results 441 - 460
of 825
Sorted by Relevance
|
Sort by Date
29 Jun 2010, 6:01 pm
(Docket Report) US: District Court Delaware: Failure to disclose sample size of test does not constitute inequitable conduct: Senju Pharmaceutical Co. [read post]
30 Nov 2011, 8:22 am
New Jersey v. [read post]
8 Feb 2017, 3:26 pm
This post examines an opinion from the Superior Court of New Jersey – Appellate Division: State v. [read post]
11 Aug 2014, 7:01 am
Courts in a few states follow this method, e.g., Delaware, Utah, and a 1994 New York case. [read post]
6 Mar 2014, 12:41 pm
April 11, 2013) ("[the drug] is approved by the FDA, and therefore, this approval is a complete defense to a [New York law] claim"); Cytyc Corp. v. [read post]
19 Aug 2021, 12:34 pm
The New Jersey Department of Labor and Workforce Development [DLWD] has proposed Rules that will adopt the recommendations of NJ State Comptroller. [read post]
5 Dec 2022, 4:23 am
The Care One Case The above facts are drawn from a not-for-publication opinion handed down last month by a three-judge panel of the New Jersey Appellate Division — that state’s intermediate appellate court — in a case captioned Care One, LLC, et al. v Adina Straus and Jeffrey Rubin. [read post]
3 Jun 2010, 1:37 pm
That didn’t warrant applying New Jersey law because, like Michigan, the New Jersey statute had been enacted to limit manufacturer liability. [read post]
7 Apr 2010, 4:30 am
: The Medicines Company v Kappos (Peter Zura's 271 Patent Blog) Cancidas (Caspofungin) – US: District Court New Jersey: Merck & Co files patent infringement complaint following Para IV challenge by Sandoz (Patent Docs) Clarinex (Desloratadine) - US: Mass forfeiture of 180-day exclusivity! [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Opana (Oxymorphone) - US: District Court New Jersey: Patent infringement complaint following a Paragraph IV Certification: Endo Pharmaceuticals Inc. et al. v. [read post]
3 May 2012, 5:04 pm
Lacking any precedent one way or the other in Pennsylvania, Plaintiff urges this Court to look to Delaware for this issue of corporate law and to look to New Jersey, which is also in accord. [read post]
30 Aug 2024, 3:00 am
In a few of the biggest Supreme Court decisions of the last few years – including Dobbs v. [read post]
7 Jul 2009, 7:39 am
Since I practice in the Third Circuit (Pennsylvania, New Jersey and Delaware), I'll focus on the Third Circuit's most recent opinion on the CFAA: The District Court focused on the criminal provisions and found it difficult to infer a civil application within the statutory framework and concluded that it could not do so, although the Court did acknowledge that several other courts had determined to the contrary. [read post]
2 Oct 2012, 1:08 pm
Bello, Ayuda Equity Funding LLC, and Amerifund Capital Holdings, LLC Case number: 12-cv-3794 (United States District Court for the District of New Jersey) Case filed: June 25, 2012 Qualifying Judgment/Order: July 5, 2012 09/04/2012 12/03/2012 2012-84 SEC v. [read post]
26 Aug 2022, 4:00 am
Rivera’s Interamerican Consulting was sued by PDV USA, a Delaware-based affiliate of Venezuelan-owned Citgo. [read post]
30 Jul 2014, 5:30 pm
Prepare to wait – DOS passport and visa issuance database crash has worldwide impact – New Jersey lawyer Alka Bahal of Fox Rothschild on the firm’s blog, Immigration View Comic-Con v. [read post]
10 Aug 2015, 10:46 am
The court began its analysis by describing the holdings of the two leading cases on the issue: New Jersey’s Dendrite Int’l, Inc. v. [read post]
15 Jan 2013, 6:37 am
New Jersey, holding that facts increasing the defendant’s statutory maximum sentence must be found by a jury. [read post]
25 May 2011, 4:59 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
31 Jul 2016, 1:44 pm
Third Circuit, Which Covers Federal Lawsuits Brought in Pennsylvania, Delaware, New Jersey and the Virgin Islands, is That Money Recovered by Employees in Family and Medical Leave Act Cases is to be Treated as 1099 Miscellaneous IncomeIn a 1998 decision, Churchill v. [read post]
